CUSIP: 86877M209
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,454,610
-
Share change
-
-7,462,999
-
Total reported value
-
$16,920,778
-
Put/Call ratio
-
39%
-
Price per share
-
$0.87
-
Number of holders
-
61
-
Value change
-
-$5,025,368
-
Number of buys
-
18
-
Number of sells
-
37
Quarterly Holders Quick Answers
What is CUSIP 86877M209?
CUSIP 86877M209 identifies SURF - SURFACE ONCOLOGY INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2023
-
Previous quarter:
Q1 2023
Recent filing periods for CUSIP 86877M209:
Institutional Holders of SURFACE ONCOLOGY INC - COM (SURF) as of Q2 2023
As of 30 Jun 2023,
SURFACE ONCOLOGY INC - COM (SURF) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,454,610 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Atlas Venture Associates IX, LLC, VANGUARD GROUP INC, ARK Investment Management LLC, DAFNA Capital Management LLC, ACADIAN ASSET MANAGEMENT LLC, Yakira Capital Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, Laurion Capital Management LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.